Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Mar 14 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-mar-14-2023-3

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 14, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Clindamycin HydrochlorideCapsules USP, 75 mg, 150 mg, and 300 mg".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases